Geriatrics News

A treatment involving broadband light improved the clinical appearance of senile purpura and prevented future lesions, according to a presentation at the American Society for Dermatologic Surgery annual meeting.

Dipeptidyl peptidase-4 inhibition to treat type 2 diabetes was associated with an elevated risk for bullous pemphigoid, according to a study.

Rituximab contributed to reaching complete remission and reduced steroid use in patients with bullous pemphigoid, but did not increase overall survival, according to a poster presented at the American Academy of Dermatology virtual meeting.

Patients hospitalized for dermatologic issues with concomitant micronutrient deficiencies had a significantly increased length of stay and higher 30-day mortality rates, according to a study.

by Rodney Sinclair, MD

Researchers compiled a treatment algorithm for cutaneous manifestations of lupus erythematosus based on data from 104 studies, according to a study presented at the American College of Rheumatology/Association of Rheumatology Professionals annual meeting.

In the dermatology setting, researchers found a substantial delay from symptom onset to a psoriatic arthritis diagnosis compared with rheumatology, according to LOOP, a multicenter study across 44 sites in the U.S.

Among topical dermatologic drugs, the mean overpayment for brand-name drugs was more than double that of generics, based on an analysis of claims data of privately insured individuals published in JAMA Dermatology.

Dupilumab significantly improved atopic dermatitis signs, symptoms and quality of life in Asian, black and white patients, according to a pooled analysis of three phase 3 trials.

Dermatological hospital readmission rates have remained constant, leading researchers to suggest improvements in both outpatient management of skin diseases and inpatient care.